EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 8 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $26,297 | -32.6% | 2,635 | -32.6% | 0.00% | – |
Q3 2022 | $39,000 | -2.5% | 3,910 | -2.2% | 0.00% | – |
Q2 2022 | $40,000 | +2.6% | 4,000 | 0.0% | 0.00% | – |
Q1 2022 | $39,000 | +254.5% | 4,000 | +261.3% | 0.00% | – |
Q1 2021 | $11,000 | -68.6% | 1,107 | -67.1% | 0.00% | – |
Q4 2020 | $35,000 | – | 3,360 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 400,000 | $4,264,000 | 1.59% |
Endurant Capital Management LP | 195,000 | $2,079,000 | 0.75% |
CVI Holdings, LLC | 355,000 | $3,784,000 | 0.71% |
Wealthspring Capital LLC | 129,880 | $1,385,000 | 0.69% |
Sio Capital Management, LLC | 300,000 | $3,198,000 | 0.66% |
Monashee Investment Management LLC | 300,000 | $3,198,000 | 0.42% |
Sage Mountain Advisors LLC | 95,970 | $1,023,000 | 0.34% |
683 Capital Management, LLC | 600,000 | $6,396,000 | 0.30% |
LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $2,138,000 | 0.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $2,132,000 | 0.23% |